The Clinical Diagnostic Value of Combined Detection of miR-146a, UAER, and Other Indicators for Early-Stage Type 2 Diabetic Nephropathy
-
Published:2024
Issue:07
Volume:14
Page:1138-1146
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference20 articles.
1. Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
2. Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
3. Cell mediated ECM-degradation as an emerging tool for anti-fibrotic strategy
4. Satta, E., Strollo, F., Borgia, L., et al. (2023) Urinary L-FABP: A Potential Novel Early Biomarker for Diabetic Nephropathy? A Systematic Review of the Literature. Research Square, 1-11.
5. Rossing, P. and Flyvbjerg, A. (2024) Diabetic Nephropathy. In: Holt, Richard, I.G., Cockram, C., Flyvbjerg, A. and Goldstein, B.J., Eds., Textbook of Diabetes, Blackwell, 640-654.